Glenmark Pharma gets USFDA nod for ear drops

| | New Delhi
  • 0

Glenmark Pharma gets USFDA nod for ear drops

Tuesday, 18 December 2018 | PTI | New Delhi

Glenmark Pharma gets USFDA nod for ear drops

Glenmark Pharmaceuticals Tuesday said it has received final approval from the US health regulator for Fluocinolone Acetonide Oil, used to treat eczema of the ear.

Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Fluocinolone Acetonide Oil, 0.01 per cent (ear drops), a generic version of DermOtic Oil, 0.01 per cent of Hill Dermaceuticals, Inc," the company said in a BSE filing.

Quoting IQVIA sales data for the 12 month period ending October 2018, Glenmark said, the DermaOtic Oil, 0.01 per cent market achieved annual sales of approximately USD 18.1 million.

The company's current portfolio consists of 146 products authorised for distribution at the US marketplace and 54 abbreviated new drug applications (ANDAs) pending approval with the USFDA.

The company's stock was trading at Rs 686.30 apiece, up 0.42 per cent, on the BSE.

Sunday Edition

CAA PASSPORT TO FREEDOM

24 March 2024 | Kumar Chellappan | Agenda

CHENNAI EXPRESS IN GURUGRAM

24 March 2024 | Pawan Soni | Agenda

The Way of Bengal

24 March 2024 | Shobori Ganguli | Agenda

The Pizza Philosopher

24 March 2024 | Shobori Ganguli | Agenda

Astroturf | Lord Shiva calls for all-inclusiveness

24 March 2024 | Bharat Bhushan Padmadeo | Agenda

Interconnected narrative l Forest conservation l Agriculture l Food security

24 March 2024 | BKP Sinha/ Arvind K jha | Agenda